Literature DB >> 15451793

ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver.

Paolo Parini1, Matthew Davis, Aaron T Lada, Sandra K Erickson, Teresa L Wright, Ulf Gustafsson, Staffan Sahlin, Curt Einarsson, Mats Eriksson, Bo Angelin, Hiroshi Tomoda, Satoshi Omura, Mark C Willingham, Lawrence L Rudel.   

Abstract

BACKGROUND: Two acyl-coenzyme A:cholesterol acyltransferase (ACAT) genes, ACAT1 and ACAT2, have been identified that encode 2 proteins responsible for intracellular cholesterol esterification. METHODS AND
RESULTS: In this study, immunohistology was used to establish their cellular localization in human liver biopsies. ACAT2 protein expression was confined to hepatocytes, whereas ACAT1 protein was found in Kupffer cells only. Studies with a highly specific ACAT2 inhibitor, pyripyropene A, in microsomal activity assays demonstrated that ACAT2 activity was highly variable among individual human liver samples, whereas ACAT1 activity was more similar in all specimens. ACAT2 provided the major cholesterol-esterifying activity in 3 of 4 human liver samples examined.
CONCLUSIONS: The data suggest that in diseases in which dysregulation of cholesterol metabolism occurs, such as hypercholesterolemia and atherosclerosis, ACAT2 should be considered a target for prevention and treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15451793     DOI: 10.1161/01.CIR.0000143163.76212.0B

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  73 in total

1.  Rat carboxylesterase ES-4 enzyme functions as a major hepatic neutral cholesteryl ester hydrolase.

Authors:  Saj Parathath; Snjezana Dogan; Victor A Joaquin; Snigdha Ghosh; Liang Guo; Ginny L Weibel; George H Rothblat; Earl H Harrison; Edward A Fisher
Journal:  J Biol Chem       Date:  2011-09-20       Impact factor: 5.157

2.  Multiple mechanisms limit the accumulation of unesterified cholesterol in the small intestine of mice deficient in both ACAT2 and ABCA1.

Authors:  Stephen D Turley; Mark A Valasek; Joyce J Repa; John M Dietschy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-08-19       Impact factor: 4.052

3.  Abolished synthesis of cholic acid reduces atherosclerotic development in apolipoprotein E knockout mice.

Authors:  Katharina Slätis; Mats Gåfvels; Kristina Kannisto; Olga Ovchinnikova; Gabrielle Paulsson-Berne; Paolo Parini; Zhao-Yan Jiang; Gösta Eggertsen
Journal:  J Lipid Res       Date:  2010-07-30       Impact factor: 5.922

4.  LDL particle core enrichment in cholesteryl oleate increases proteoglycan binding and promotes atherosclerosis.

Authors:  John T Melchior; Janet K Sawyer; Kathryn L Kelley; Ramesh Shah; Martha D Wilson; Roy R Hantgan; Lawrence L Rudel
Journal:  J Lipid Res       Date:  2013-06-26       Impact factor: 5.922

Review 5.  Acyl-coenzyme A:cholesterol acyltransferases.

Authors:  Ta-Yuan Chang; Bo-Liang Li; Catherine C Y Chang; Yasuomi Urano
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-01-13       Impact factor: 4.310

6.  Diosgenin stimulation of fecal cholesterol excretion in mice is not NPC1L1 dependent.

Authors:  Ryan E Temel; J Mark Brown; Yinyan Ma; Weiqing Tang; Lawrence L Rudel; Yiannis A Ioannou; Joanna P Davies; Liqing Yu
Journal:  J Lipid Res       Date:  2009-01-13       Impact factor: 5.922

7.  PRD125, a potent and selective inhibitor of sterol O-acyltransferase 2 markedly reduces hepatic cholesteryl ester accumulation and improves liver function in lysosomal acid lipase-deficient mice.

Authors:  Adam M Lopez; Jen-Chieh Chuang; Kenneth S Posey; Taichi Ohshiro; Hiroshi Tomoda; Lawrence L Rudel; Stephen D Turley
Journal:  J Pharmacol Exp Ther       Date:  2015-08-17       Impact factor: 4.030

8.  Identification of the interaction site within acyl-CoA:cholesterol acyltransferase 2 for the isoform-specific inhibitor pyripyropene A.

Authors:  Akash Das; Matthew A Davis; Hiroshi Tomoda; Satoshi Omura; Lawrence L Rudel
Journal:  J Biol Chem       Date:  2008-02-19       Impact factor: 5.157

9.  Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss.

Authors:  J Mark Brown; Thomas A Bell; Heather M Alger; Janet K Sawyer; Thomas L Smith; Kathryn Kelley; Ramesh Shah; Martha D Wilson; Matthew A Davis; Richard G Lee; Mark J Graham; Rosanne M Crooke; Lawrence L Rudel
Journal:  J Biol Chem       Date:  2008-02-14       Impact factor: 5.157

10.  Cholesterol synthesis inhibition elicits an integrated molecular response in human livers including decreased ACAT2.

Authors:  Paolo Parini; Ulf Gustafsson; Matt A Davis; Lilian Larsson; Curt Einarsson; Martha Wilson; Mats Rudling; Hiroshi Tomoda; Satoshi Omura; Staffan Sahlin; Bo Angelin; Lawrence L Rudel; Mats Eriksson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03-13       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.